Basilea Pharmaceutica - Milestone march continues for Cresemba
Basilea Pharmaceutica has reported another US$1.25m milestone payment from its partner Pfizer in Asia-Pacific and China, triggered by Cresemba...
235 Views
Basilea Pharmaceutica - BARDA backs Basilea’s anti-infectives programme
Basilea has bagged a multi-year agreement with the Biomedical Advanced Research and Development Authority (BARDA), potentially worth US$268m, to...
207 Views
Basilea Pharmaceutica - H2 rewards continue: US$25m Cresemba milestone
H224 continues to be a rewarding period for Basilea Pharmaceutica, with the announcement of a third successive milestone payment for Cresemba in...
231 Views
Basilea Pharmaceutica - EU paediatric approval triggers CHF10m milestone
Basilea has announced yet another milestone following the European Commission (EC) approval for Cresemba’s use in the paediatric population (in...
173 Views
Basilea Pharmaceutica - Another Cresemba milestone payment in the bank
The uptrend in Cresemba sales in Asia-Pacific and China triggered the receipt of Basilea’s third milestone payment of US$1.25m from Pfizer for the...
236 Views